Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-02

AUTHORS

A M Gonzalez-Angulo, N Parinyanitikul, X Lei, E A Mittendorf, H Zhang, V Valero, K K Hunt, G N Hortobagyi, M Chavez-MacGregor

ABSTRACT

PURPOSE: To study the impact of adjuvant trastuzumab among patients achieving a pathologic complete response (pCR) after trastuzumab-based neoadjuvant systemic therapy (NST). PATIENTS AND METHODS: Patients with primary HER2-positive breast cancer treated with trastuzumab-based NST were categorised according to adjuvant trastuzumab administration and pCR status. Adjuvant trastuzumab became standard of care in 2006, this was the main reason patients in our cohort did not receive adjuvant trastuzumab. Kaplan-Meier was used to estimate survival. A test for interaction between adjuvant trastuzumab and pCR was completed. FINDINGS: Of 589 patients, 203 (34.5%) achieved a pCR. After surgery, 109 (18.5%) patients in the entire cohort did not receive adjuvant trastuzumab. Among patients achieving a pCR, 31.3% received adjuvant trastuzumab compared with 68.8% among those who did not achieve a pCR (P=0.0006). Among patients achieving pCR, adjuvant trastuzumab did not further improve overall survival (OS) or relapse-free survival (RFS) (P=0.35 and P=0.93, respectively). Any benefit of adjuvant trastuzumab in OS and RFS among patients without a pCR did not achieve statistical significance (P=0.3 and P=0.44, respectively). CONCLUSIONS: In this cohort, patients treated with trastuzumab-based NST who achieved a pCR have excellent outcome regardless of whether they received adjuvant trastuzumab. More... »

PAGES

630

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2014.647

DOI

http://dx.doi.org/10.1038/bjc.2014.647

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023251803

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25584488


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Ductal, Breast", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epirubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Paclitaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Trastuzumab", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA", 
            "Department of Systems Biology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonzalez-Angulo", 
        "givenName": "A M", 
        "id": "sg:person.015372217444.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015372217444.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parinyanitikul", 
        "givenName": "N", 
        "id": "sg:person.01225224665.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225224665.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Biostatistics at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lei", 
        "givenName": "X", 
        "id": "sg:person.01324104373.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324104373.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mittendorf", 
        "givenName": "E A", 
        "id": "sg:person.01277610130.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277610130.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "H", 
        "id": "sg:person.01041463525.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041463525.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valero", 
        "givenName": "V", 
        "id": "sg:person.013666404777.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013666404777.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hunt", 
        "givenName": "K K", 
        "id": "sg:person.01340214713.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340214713.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hortobagyi", 
        "givenName": "G N", 
        "id": "sg:person.01365732165.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365732165.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA", 
            "Department of Health Services Research at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chavez-MacGregor", 
        "givenName": "M", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2007.15.3510", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002585977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-1345", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003769138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-014-2907-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003978502", 
          "https://doi.org/10.1007/s10549-014-2907-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61094-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005348231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70225-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006376356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70336-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006777850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdt131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007774782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.2205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012429485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26555", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012765677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.07.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014791751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)70080-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027358849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.50.9984", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028197158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.4577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036202282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70502-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043578355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(11)61847-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043834514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.31.4930", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046296004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/biomet/80.1.27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059420374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.8.2672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083305985"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-02", 
    "datePublishedReg": "2015-02-01", 
    "description": "PURPOSE: To study the impact of adjuvant trastuzumab among patients achieving a pathologic complete response (pCR) after trastuzumab-based neoadjuvant systemic therapy (NST).\nPATIENTS AND METHODS: Patients with primary HER2-positive breast cancer treated with trastuzumab-based NST were categorised according to adjuvant trastuzumab administration and pCR status. Adjuvant trastuzumab became standard of care in 2006, this was the main reason patients in our cohort did not receive adjuvant trastuzumab. Kaplan-Meier was used to estimate survival. A test for interaction between adjuvant trastuzumab and pCR was completed.\nFINDINGS: Of 589 patients, 203 (34.5%) achieved a pCR. After surgery, 109 (18.5%) patients in the entire cohort did not receive adjuvant trastuzumab. Among patients achieving a pCR, 31.3% received adjuvant trastuzumab compared with 68.8% among those who did not achieve a pCR (P=0.0006). Among patients achieving pCR, adjuvant trastuzumab did not further improve overall survival (OS) or relapse-free survival (RFS) (P=0.35 and P=0.93, respectively). Any benefit of adjuvant trastuzumab in OS and RFS among patients without a pCR did not achieve statistical significance (P=0.3 and P=0.44, respectively).\nCONCLUSIONS: In this cohort, patients treated with trastuzumab-based NST who achieved a pCR have excellent outcome regardless of whether they received adjuvant trastuzumab.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2014.647", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "112"
      }
    ], 
    "name": "Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy", 
    "pagination": "630", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6ec6cf69898d8fa9a044fa2a5be5d219e1691af653353228f29153348571087c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25584488"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2014.647"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023251803"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2014.647", 
      "https://app.dimensions.ai/details/publication/pub.1023251803"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000550.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc2014647"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.647'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.647'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.647'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2014.647'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      21 PREDICATES      68 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2014.647 schema:about N06e5f15815ab4d1eb0623fd2e350e321
2 N18f56b65ea2542029ad11d45e153b090
3 N1ba8f26a8965439e86c5db12eb0916eb
4 N37593396ff6d4ec9b724e825f59bb782
5 N448b9a38a81b4249bb168af8873513da
6 N4f8a5c4a381b4e30b0bd388f2f038b43
7 N5025e1d46e1f470a93745bb46155d7e3
8 N5ad3f24330b0421f852f1252322d7eda
9 N6546709b801d4f9e8b11c6126c655357
10 N6c315c47514f434aab21d4a4795a4e85
11 N6c5f7e020de54369b432f08018a06a96
12 N76ee3d014fcc4250b9044339541fa6ab
13 N7e993cccead04ac79c6e7220b8a38bd5
14 N85f2d7f1341c47268a8a2d2d70a34ada
15 N9f72760100ad4edba2c2ad371216c82e
16 Nb2013ed2a2e14a73b3e2cc5787dab3d8
17 Nbde1618d26654348997f96abddba9238
18 Ncdcf57840ae94287beb59665a6bbc877
19 Ndb0ccf667b904cf8afc213685f1c1228
20 Nf37ceb65d8f84aa58b31f2ad370efee2
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author N115b3c44e78345c18384ddc6273e03da
24 schema:citation sg:pub.10.1007/s10549-014-2907-9
25 https://doi.org/10.1002/cncr.26555
26 https://doi.org/10.1016/s0140-6736(11)61847-3
27 https://doi.org/10.1016/s0140-6736(13)61094-6
28 https://doi.org/10.1016/s0140-6736(13)62422-8
29 https://doi.org/10.1016/s1470-2045(11)70336-9
30 https://doi.org/10.1016/s1470-2045(13)70225-0
31 https://doi.org/10.1016/s1470-2045(13)70502-3
32 https://doi.org/10.1016/s1470-2045(14)70080-4
33 https://doi.org/10.1093/annonc/mdt131
34 https://doi.org/10.1093/biomet/80.1.27
35 https://doi.org/10.1158/1078-0432.ccr-06-1345
36 https://doi.org/10.1200/jco.1998.16.8.2672
37 https://doi.org/10.1200/jco.2005.07.032
38 https://doi.org/10.1200/jco.2007.15.3510
39 https://doi.org/10.1200/jco.2008.21.4577
40 https://doi.org/10.1200/jco.2009.25.2205
41 https://doi.org/10.1200/jco.2010.31.4930
42 https://doi.org/10.1200/jco.2013.50.9984
43 schema:datePublished 2015-02
44 schema:datePublishedReg 2015-02-01
45 schema:description PURPOSE: To study the impact of adjuvant trastuzumab among patients achieving a pathologic complete response (pCR) after trastuzumab-based neoadjuvant systemic therapy (NST). PATIENTS AND METHODS: Patients with primary HER2-positive breast cancer treated with trastuzumab-based NST were categorised according to adjuvant trastuzumab administration and pCR status. Adjuvant trastuzumab became standard of care in 2006, this was the main reason patients in our cohort did not receive adjuvant trastuzumab. Kaplan-Meier was used to estimate survival. A test for interaction between adjuvant trastuzumab and pCR was completed. FINDINGS: Of 589 patients, 203 (34.5%) achieved a pCR. After surgery, 109 (18.5%) patients in the entire cohort did not receive adjuvant trastuzumab. Among patients achieving a pCR, 31.3% received adjuvant trastuzumab compared with 68.8% among those who did not achieve a pCR (P=0.0006). Among patients achieving pCR, adjuvant trastuzumab did not further improve overall survival (OS) or relapse-free survival (RFS) (P=0.35 and P=0.93, respectively). Any benefit of adjuvant trastuzumab in OS and RFS among patients without a pCR did not achieve statistical significance (P=0.3 and P=0.44, respectively). CONCLUSIONS: In this cohort, patients treated with trastuzumab-based NST who achieved a pCR have excellent outcome regardless of whether they received adjuvant trastuzumab.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree true
49 schema:isPartOf N2369de771774491ba5f883036f7484bb
50 Nbadaf2c2d03142a791f251fac90af470
51 sg:journal.1017082
52 schema:name Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy
53 schema:pagination 630
54 schema:productId N2c70b6eb31c14d5fbcbb11860abccf45
55 N2d5ed47716674259afb5c1eb723d13b5
56 N99ae258b1c2b45688fd73f90302861ec
57 Nf4a404831a0647878ce5476ed96734a7
58 Nfc4561df53cd49269c43e534c3941536
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023251803
60 https://doi.org/10.1038/bjc.2014.647
61 schema:sdDatePublished 2019-04-10T20:03
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N665079b3799d41cc81f565a80adcf712
64 schema:url https://www.nature.com/articles/bjc2014647
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N06e5f15815ab4d1eb0623fd2e350e321 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Middle Aged
70 rdf:type schema:DefinedTerm
71 N115b3c44e78345c18384ddc6273e03da rdf:first sg:person.015372217444.01
72 rdf:rest Nf31cae9f955a4728ad57281ed1dc0f9c
73 N18f56b65ea2542029ad11d45e153b090 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Paclitaxel
75 rdf:type schema:DefinedTerm
76 N1ba8f26a8965439e86c5db12eb0916eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Antibodies, Monoclonal, Humanized
78 rdf:type schema:DefinedTerm
79 N2369de771774491ba5f883036f7484bb schema:volumeNumber 112
80 rdf:type schema:PublicationVolume
81 N23872a95c56b493fae75506b8e506f55 rdf:first sg:person.01277610130.61
82 rdf:rest Na699d76c427c4a1288620f2283bd12fd
83 N2c70b6eb31c14d5fbcbb11860abccf45 schema:name dimensions_id
84 schema:value pub.1023251803
85 rdf:type schema:PropertyValue
86 N2d5ed47716674259afb5c1eb723d13b5 schema:name readcube_id
87 schema:value 6ec6cf69898d8fa9a044fa2a5be5d219e1691af653353228f29153348571087c
88 rdf:type schema:PropertyValue
89 N37593396ff6d4ec9b724e825f59bb782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Retrospective Studies
91 rdf:type schema:DefinedTerm
92 N40607460108943398fb8cce66080e830 rdf:first Ndb8ca9eff59a4b6fbff3fded192fc711
93 rdf:rest rdf:nil
94 N448b9a38a81b4249bb168af8873513da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Humans
96 rdf:type schema:DefinedTerm
97 N47649a2c17a5407faf8a8255e5cbb2f8 rdf:first sg:person.01365732165.24
98 rdf:rest N40607460108943398fb8cce66080e830
99 N4dce0588b42e4b2893a4100659eb232c rdf:first sg:person.01340214713.66
100 rdf:rest N47649a2c17a5407faf8a8255e5cbb2f8
101 N4f8a5c4a381b4e30b0bd388f2f038b43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Carcinoma, Ductal, Breast
103 rdf:type schema:DefinedTerm
104 N5025e1d46e1f470a93745bb46155d7e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Protein Kinase Inhibitors
106 rdf:type schema:DefinedTerm
107 N5ad3f24330b0421f852f1252322d7eda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Epirubicin
109 rdf:type schema:DefinedTerm
110 N6546709b801d4f9e8b11c6126c655357 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Neoadjuvant Therapy
112 rdf:type schema:DefinedTerm
113 N665079b3799d41cc81f565a80adcf712 schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N6c315c47514f434aab21d4a4795a4e85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Receptor, ErbB-2
117 rdf:type schema:DefinedTerm
118 N6c5f7e020de54369b432f08018a06a96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Cyclophosphamide
120 rdf:type schema:DefinedTerm
121 N76ee3d014fcc4250b9044339541fa6ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Chemotherapy, Adjuvant
123 rdf:type schema:DefinedTerm
124 N7e993cccead04ac79c6e7220b8a38bd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Trastuzumab
126 rdf:type schema:DefinedTerm
127 N834881ca41594308a0104a04ceb6ba0c rdf:first sg:person.013666404777.83
128 rdf:rest N4dce0588b42e4b2893a4100659eb232c
129 N85f2d7f1341c47268a8a2d2d70a34ada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Aged
131 rdf:type schema:DefinedTerm
132 N8f1c0cb2e50f4bda9fe22f76be14432f rdf:first sg:person.01324104373.10
133 rdf:rest N23872a95c56b493fae75506b8e506f55
134 N99ae258b1c2b45688fd73f90302861ec schema:name nlm_unique_id
135 schema:value 0370635
136 rdf:type schema:PropertyValue
137 N9f72760100ad4edba2c2ad371216c82e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Fluorouracil
139 rdf:type schema:DefinedTerm
140 Na699d76c427c4a1288620f2283bd12fd rdf:first sg:person.01041463525.15
141 rdf:rest N834881ca41594308a0104a04ceb6ba0c
142 Nb2013ed2a2e14a73b3e2cc5787dab3d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Aged, 80 and over
144 rdf:type schema:DefinedTerm
145 Nbadaf2c2d03142a791f251fac90af470 schema:issueNumber 4
146 rdf:type schema:PublicationIssue
147 Nbde1618d26654348997f96abddba9238 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Breast Neoplasms
149 rdf:type schema:DefinedTerm
150 Ncdcf57840ae94287beb59665a6bbc877 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Female
152 rdf:type schema:DefinedTerm
153 Ndb0ccf667b904cf8afc213685f1c1228 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Antineoplastic Combined Chemotherapy Protocols
155 rdf:type schema:DefinedTerm
156 Ndb8ca9eff59a4b6fbff3fded192fc711 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
157 schema:familyName Chavez-MacGregor
158 schema:givenName M
159 rdf:type schema:Person
160 Nf31cae9f955a4728ad57281ed1dc0f9c rdf:first sg:person.01225224665.52
161 rdf:rest N8f1c0cb2e50f4bda9fe22f76be14432f
162 Nf37ceb65d8f84aa58b31f2ad370efee2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Adult
164 rdf:type schema:DefinedTerm
165 Nf4a404831a0647878ce5476ed96734a7 schema:name pubmed_id
166 schema:value 25584488
167 rdf:type schema:PropertyValue
168 Nfc4561df53cd49269c43e534c3941536 schema:name doi
169 schema:value 10.1038/bjc.2014.647
170 rdf:type schema:PropertyValue
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
175 schema:name Oncology and Carcinogenesis
176 rdf:type schema:DefinedTerm
177 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1038/bjc.2014.647
178 rdf:type schema:MonetaryGrant
179 sg:journal.1017082 schema:issn 0007-0920
180 1532-1827
181 schema:name British Journal of Cancer
182 rdf:type schema:Periodical
183 sg:person.01041463525.15 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
184 schema:familyName Zhang
185 schema:givenName H
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041463525.15
187 rdf:type schema:Person
188 sg:person.01225224665.52 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
189 schema:familyName Parinyanitikul
190 schema:givenName N
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225224665.52
192 rdf:type schema:Person
193 sg:person.01277610130.61 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
194 schema:familyName Mittendorf
195 schema:givenName E A
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277610130.61
197 rdf:type schema:Person
198 sg:person.01324104373.10 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
199 schema:familyName Lei
200 schema:givenName X
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324104373.10
202 rdf:type schema:Person
203 sg:person.01340214713.66 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
204 schema:familyName Hunt
205 schema:givenName K K
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340214713.66
207 rdf:type schema:Person
208 sg:person.01365732165.24 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
209 schema:familyName Hortobagyi
210 schema:givenName G N
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365732165.24
212 rdf:type schema:Person
213 sg:person.013666404777.83 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
214 schema:familyName Valero
215 schema:givenName V
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013666404777.83
217 rdf:type schema:Person
218 sg:person.015372217444.01 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
219 schema:familyName Gonzalez-Angulo
220 schema:givenName A M
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015372217444.01
222 rdf:type schema:Person
223 sg:pub.10.1007/s10549-014-2907-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003978502
224 https://doi.org/10.1007/s10549-014-2907-9
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1002/cncr.26555 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012765677
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/s0140-6736(11)61847-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043834514
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/s0140-6736(13)61094-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005348231
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/s0140-6736(13)62422-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038142448
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s1470-2045(11)70336-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006777850
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s1470-2045(13)70225-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006376356
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s1470-2045(13)70502-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043578355
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s1470-2045(14)70080-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027358849
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1093/annonc/mdt131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007774782
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1093/biomet/80.1.27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059420374
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1158/1078-0432.ccr-06-1345 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003769138
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.1998.16.8.2672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083305985
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2005.07.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014791751
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1200/jco.2007.15.3510 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002585977
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1200/jco.2008.21.4577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036202282
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1200/jco.2009.25.2205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012429485
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1200/jco.2010.31.4930 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046296004
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1200/jco.2013.50.9984 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028197158
261 rdf:type schema:CreativeWork
262 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
263 schema:name Department of Biostatistics at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
264 Department of Breast Medical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
265 Department of Health Services Research at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
266 Department of Pathology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
267 Department of Surgical Oncology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
268 Department of Systems Biology at The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...